An advisory committee for the U.S. Centers for Disease Control and Prevention voted unanimously December 16 to recommend mRNA COVID-19 vaccines over Johnson & Johnson’s shot.
When there is a choice, people seeking a COVID-19 shot should be told that the mRNA vaccines, made by Moderna and by Pfizer and its German partner BioNtech, are safer and more effective and are the preferred option.
But people who have allergies to ingredients in the mRNA vaccines and those who want the single-dose vaccine can still opt to get J&J’s vaccine. The benefits of that shot, authorized for those 18 and older, still outweigh the risks. And as a single-shot vaccine,
→ Continue reading at Science News